The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, G.
Right arrow Articles by Brunham, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, G.
Right arrow Articles by Brunham, R. C.

The Journal of Immunology, Vol 151, Issue 7 3728-3736, Copyright © 1993 by American Association of Immunologists


ARTICLES

Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis

G Zhong, I Toth, R Reid and RC Brunham
Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.

Lipidic amino acid-based synthetic peptides derived from the variable domains (VD) of Chlamydia trachomatis outer membrane protein 1 were evaluated as potential candidate sequences in a vaccine. A peptide sequence designated P2 from the VD IV of serovar B contained a B cell epitope capable of eliciting antibodies binding to serovar B elementary bodies (EB) and a T helper site capable of presentation by multiple H-2 alleles. Polymerization of the P2 into polylysine to form lipid core peptides (LCP) significantly enhanced immunogenicity compared with P2 monomer alone. The LCP system incorporates lipidic amino acids into the polylysine system and enhances lipophobicity and membrane binding effects of the peptide. A second peptide sequence derived from the VD I of serovar C was cosynthesized with P2 into lipidic polylysine LCP and was designated LCP-H1. Antibodies to this construct reacted at high titer with EB of the three major trachoma causing C. trachomatis serovars A, B, and C. LCP-H1 was immunogenic among four of five murine H-2 alleles. Pepscan analysis showed that the fine specificity of antibodies generated to LCP-H1 were directed to the predetermined neutralizing epitope sequences. An in vitro HAK cell neutralization assay showed that LCP-H1 elicited neutralizing antibodies to serovars A, B, and C, but these were of low titer. Because LCP-H1 antibodies bound to the peptide sequence with 10-100-fold higher titer than to EB, the low neutralization titers most likely result from conformational differences between the synthetic peptide and antigenic sites on the native organism. Modification of LCP-H1 to incorporate a predefined conformation may result in improved antigenic properties.


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Zhang, L. Gao, L. Lei, Y. Zhong, P. Dube, M. T. Berton, B. Arulanandam, J. Zhang, and G. Zhong
A MyD88-Dependent Early IL-17 Production Protects Mice against Airway Infection with the Obligate Intracellular Pathogen Chlamydia muridarum
J. Immunol., July 15, 2009; 183(2): 1291 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Chen, W. Cheng, P. Shivshankar, L. Lei, X. Zhang, Y. Wu, I-T. Yeh, and G. Zhong
Distinct Roles of CD28- and CD40 Ligand-Mediated Costimulation in the Development of Protective Immunity and Pathology during Chlamydia muridarum Urogenital Infection in Mice
Infect. Immun., July 1, 2009; 77(7): 3080 - 3089.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Li, D. Chen, Y. Zhong, S. Wang, and G. Zhong
The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells
Infect. Immun., August 1, 2008; 76(8): 3415 - 3428.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Li, C. Chen, D. Chen, Y. Wu, Y. Zhong, and G. Zhong
Characterization of Fifty Putative Inclusion Membrane Proteins Encoded in the Chlamydia trachomatis Genome
Infect. Immun., June 1, 2008; 76(6): 2746 - 2757.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. Cheng, P. Shivshankar, Y. Zhong, D. Chen, Z. Li, and G. Zhong
Intracellular Interleukin-1{alpha} Mediates Interleukin-8 Production Induced by Chlamydia trachomatis Infection via a Mechanism Independent of Type I Interleukin-1 Receptor
Infect. Immun., March 1, 2008; 76(3): 942 - 951.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. Cheng, P. Shivshankar, Z. Li, L. Chen, I-T. Yeh, and G. Zhong
Caspase-1 Contributes to Chlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection
Infect. Immun., February 1, 2008; 76(2): 515 - 522.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
R. Flores, J. Luo, D. Chen, G. Sturgeon, P. Shivshankar, Y. Zhong, and G. Zhong
Characterization of the hypothetical protein Cpn1027, a newly identified inclusion membrane protein unique to Chlamydia pneumoniae
Microbiology, March 1, 2007; 153(3): 777 - 786.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Chen, D. Chen, J. Sharma, W. Cheng, Y. Zhong, K. Liu, J. Jensen, R. Shain, B. Arulanandam, and G. Zhong
The Hypothetical Protein CT813 Is Localized in the Chlamydia trachomatis Inclusion Membrane and Is Immunogenic in Women Urogenitally Infected with C. trachomatis.
Infect. Immun., August 1, 2006; 74(8): 4826 - 4840.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Sharma, Y. Zhong, F. Dong, J. M. Piper, G. Wang, and G. Zhong
Profiling of Human Antibody Responses to Chlamydia trachomatis Urogenital Tract Infection Using Microplates Arrayed with 156 Chlamydial Fusion Proteins
Infect. Immun., March 1, 2006; 74(3): 1490 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Sharma, A. M. Bosnic, J. M. Piper, and G. Zhong
Human Antibody Responses to a Chlamydia-Secreted Protease Factor
Infect. Immun., December 1, 2004; 72(12): 7164 - 7171.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Dong, J. Sharma, Y. Xiao, Y. Zhong, and G. Zhong
Intramolecular Dimerization Is Required for the Chlamydia-Secreted Protease CPAF To Degrade Host Transcriptional Factors
Infect. Immun., July 1, 2004; 72(7): 3869 - 3875.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Olive, M. Batzloff, A. Horvath, T. Clair, P. Yarwood, I. Toth, and M. F. Good
Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens
Infect. Immun., May 1, 2003; 71(5): 2373 - 2383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Matthews, R. Davis, and G. P. Smith
Immunogenically Fit Subunit Vaccine Components Via Epitope Discovery from Natural Peptide Libraries
J. Immunol., July 15, 2002; 169(2): 837 - 846.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Olive, M. R. Batzloff, A. Horvath, A. Wong, T. Clair, P. Yarwood, I. Toth, and M. F. Good
A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies
Infect. Immun., May 1, 2002; 70(5): 2734 - 2738.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. U. Igietseme and A. Murdin
Induction of Protective Immunity against Chlamydia trachomatis Genital Infection by a Vaccine Based on Major Outer Membrane Protein-Lipophilic Immune Response-Stimulating Complexes
Infect. Immun., December 1, 2000; 68(12): 6798 - 6806.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Lu and G. Zhong
Interleukin-12 Production Is Required for Chlamydial Antigen-Pulsed Dendritic Cells To Induce Protection against Live Chlamydia trachomatis Infection
Infect. Immun., April 1, 1999; 67(4): 1763 - 1769.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.